209 related articles for article (PubMed ID: 12401701)
1. Neo-adjuvant and adjuvant chemotherapy of bladder cancer: Is there a role?
Sternberg CN
Ann Oncol; 2002; 13 Suppl 4():273-9. PubMed ID: 12401701
[No Abstract] [Full Text] [Related]
2. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
deVere White RW; Katz MH; Steinberg GD
J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
[No Abstract] [Full Text] [Related]
3. Current problems and needs in the treatment of pT1 G3 bladder carcinoma.
Martínez Portillo FJ; Alken P
Int Urol Nephrol; 2002; 33(1):29-40. PubMed ID: 12090335
[No Abstract] [Full Text] [Related]
4. T1 and T2 bladder cancer: selecting optimal therapy.
Soloway MS
Eur Urol; 1998; 33 Suppl 4():16-7. PubMed ID: 9615202
[No Abstract] [Full Text] [Related]
5. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
[TBL] [Abstract][Full Text] [Related]
6. Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder.
Rouanne M; Bajorin DF; Hannan R; Galsky MD; Williams SB; Necchi A; Sharma P; Powles T
Eur Urol Oncol; 2020 Dec; 3(6):728-738. PubMed ID: 33177001
[TBL] [Abstract][Full Text] [Related]
7. Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder.
Sternberg CN; Pansadoro V; Calabro F; Marini L; van Rijn A; Carli PD; Giannarelli D; Platania A; Rossetti A
Ann Oncol; 1999 Nov; 10(11):1301-5. PubMed ID: 10631456
[TBL] [Abstract][Full Text] [Related]
8. [Bladder carcinoma 1: Radical cystectomy, neoadjuvant and adjuvant therapy modalities].
Lampel A; Thüroff JW
Urologe A; 1998 Jan; 37(1):93-101. PubMed ID: 9540194
[No Abstract] [Full Text] [Related]
9. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H
Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422
[No Abstract] [Full Text] [Related]
10. [Neoadjuvant or Adjuvant Chemotherapy for Bladder Cancer?].
Hupe MC; Kramer MW; Kuczyk MA; Merseburger AS
Aktuelle Urol; 2015 May; 46(3):242-7. PubMed ID: 26077309
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of early stage small cell bladder cancer is not always dismal.
Lim JH; Sundar S
ESMO Open; 2019; 4(6):e000559. PubMed ID: 31798978
[TBL] [Abstract][Full Text] [Related]
12. Contemporary management of stage T1 transitional cell carcinoma of the bladder.
Sataa S; Yassine N; Ghassen HH; Imed BS; Mohamed C; Maher C; Ali H
Tunis Med; 2005 Dec; 83 Suppl 12():87-9. PubMed ID: 16430077
[No Abstract] [Full Text] [Related]
13. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemotherapy: meta-analysis and interpretation of results in bladder cancer].
Pollera CF
Suppl Tumori; 2004; 3(4):S59-61. PubMed ID: 15206215
[No Abstract] [Full Text] [Related]
15. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
[TBL] [Abstract][Full Text] [Related]
16. The influence of intravesical therapy on progression of superficial transitional cell carcinoma of the bladder. A metaanalytic comparison of chemotherapy versus bacilli Calmette-Guerin immunotherapy.
Montie JE
J Urol; 2005 Nov; 174(5):1783-4. PubMed ID: 16217285
[No Abstract] [Full Text] [Related]
17. Bladder cancer.
Borden LS; Clark PE; Hall MC
Curr Opin Oncol; 2003 May; 15(3):227-33. PubMed ID: 12778017
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?
Kuczyk M; Turkeri L; Hammerer P; Ravery V;
Eur Urol; 2003 Jul; 44(1):57-64. PubMed ID: 12814676
[TBL] [Abstract][Full Text] [Related]
19. [Interdisciplinary strategies for the treatment of bladder cancer].
Bauer W; Lamche M; Schramek P
Wien Med Wochenschr; 2007; 157(7-8):153-6. PubMed ID: 17492411
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.
Achkar T; Parikh RA
Urol Clin North Am; 2018 May; 45(2):257-266. PubMed ID: 29650141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]